Compare MEDP & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | CHWY |
|---|---|---|
| Founded | 1992 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.0B |
| IPO Year | 2016 | 2019 |
| Metric | MEDP | CHWY |
|---|---|---|
| Price | $471.64 | $25.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 22 |
| Target Price | ★ $498.25 | $45.14 |
| AVG Volume (30 Days) | 435.8K | ★ 7.6M |
| Earning Date | 05-12-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.98 | ★ 911.11 |
| EPS | ★ 15.28 | 0.43 |
| Revenue | N/A | ★ $11,861,335,000.00 |
| Revenue This Year | $13.11 | $8.37 |
| Revenue Next Year | $7.51 | $8.28 |
| P/E Ratio | ★ $30.76 | $60.40 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $250.05 | $23.06 |
| 52 Week High | $628.92 | $48.62 |
| Indicator | MEDP | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 40.77 |
| Support Level | $457.41 | $23.06 |
| Resistance Level | $501.30 | $34.72 |
| Average True Range (ATR) | 17.34 | 1.27 |
| MACD | 7.68 | 0.24 |
| Stochastic Oscillator | 87.87 | 46.87 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.